scholarly journals Recurrent patterns after postoperative radiotherapy for early stage endometrial cancer: A competing risk analysis model

2021 ◽  
Author(s):  
Kang Ren ◽  
Wenhui Wang ◽  
Shuai Sun ◽  
Xiaorong Hou ◽  
Ke Hu ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Risk Analysis ◽  
Early Stage ◽  
Postoperative Radiotherapy ◽  
Competing Risk ◽  
Competing Risk Analysis ◽  
Analysis Model ◽  
Recurrent Patterns ◽  
Early Stage Endometrial Cancer

scholarly journals A Novel Competing Risk Analysis Model to Determine the Role of Cervical Lordosis in Bony and Ligamentous Injuries

2018 ◽  
Vol 119 ◽  
pp. e962-e967
Author(s):  
Narayan Yoganandan ◽  
Anjishnu Banerjee ◽  
Nicholas DeVogel ◽  
Frank A. Pintar ◽  
Jamie L. Baisden
Keyword(s):  
Risk Analysis ◽  
Competing Risk ◽  
Cervical Lordosis ◽  
Competing Risk Analysis ◽  
Analysis Model

scholarly journals Evaluating Overall Survival and Competing Risks of Survival in Patients With Early Stage Breast Cancer Using a Comprehensive Nomogram

2019 ◽  
Author(s):  
Yanbo Xu ◽  
Hong Liu ◽  
Qi-Hua Cao ◽  
Jia-Li Ji ◽  
Rong-Rong Dong ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Overall Survival ◽  
Risk Analysis ◽  
Tumor Size ◽  
Cox Regression ◽  
Early Stage ◽  
Competing Risk ◽  
Competing Risk Analysis ◽  
Cox Regression Analysis ◽  
Specific Mortality

Abstract BackgroundPatients with early stage breast cancer (BC) live long but accompany with competing comorbidities. This study aims to estimate the impact of cancer and non-cancer causes of death in early stage BC patients, and further quantify the survival differences. MethodsPatients diagnosed with breast cancer between 2010 and 2016 from the Surveillance, Epidemiology, and End Results database were enrolled in the study. Cumulative incidence function (CIF) for cause-specific death and other causes of death were estimated, and the differences were tested by Gray’s test. Nomogram for estimating 3-, 4-, and 5-year overall survival, cancer-specific survival and other-cause-specific survival was established based on Cox regression analysis and Fine and Gray’s competing risk analysis. The discriminative ability, calibration and precision of the nomogram was evaluated and compared using C statistics, calibration plots and the area under receiver operating characteristic curve. Results196304 eligible patients with early-stage BC patients were enrolled in this study. Prolonged overall survival (OS) was associated with younger age, well differentiation, smaller tumor size, Luminal subtype and presence of surgery ( p <0.001). For competing events, Fine and Gray's competing risk analysis was used to validate the predictors: i ncreasing age, poorer differentiation, larger tumor size, triple negative subtype, HER2 enriched subtype and absence of surgery for cancer-specific mortality (CSM); and increasing age, larger tumor size and absence of surgery for other-cause-specific mortality (OCSM). The established nomogram was well calibrated, and displayed good discrimination in both training cohort and validation cohort by calibration plots (Figure 4), with a concordance index of 0.801 (95% CI, 0.795-0.806; p =0.003) for OS prediction; 0.830 (95% CI, 0.824-0.836; p =0.003) for CSM prediction and 0.806 (95% CI, 0.798-0.814; p =0.004) for OCSM prediction. Furthermore, the AUC values for predicting survival and death were: OS, 80.2% (3-year), 79.5% (4-year), and 78.7% (5-year); CSM, 83.0% (3-year), 81.7% (4-year), and 80.3% (5-year); OCSM 81.3% (3-year), 80.8% (4-year), and 81.7% (5-year) (Figure 5). ConclusionsWe evaluated OS and CIF of cancer-specific death and other-cause-specific death in patients with early stage BC based on Cox regression analysis and Fine and Gray’s competing risk analysis and developed the first comprehensive prognostic nomogram.

Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer

2006 ◽  
Vol 274 (2) ◽  
pp. 91-96 ◽  
Author(s):  
A. Papanikolaou ◽  
I. Kalogiannidis ◽  
M. Goutzioulis ◽  
D. Misailidou ◽  
A. Makedos ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
High Risk ◽  
Early Stage ◽  
Postoperative Radiotherapy ◽  
Pelvic Lymphadenectomy ◽  
Early Stage Endometrial Cancer

Mortality in early-stage, surgically resected non-small cell lung cancer less than 3cm of size: Competing risk analysis

2015 ◽  
Vol 145 (5) ◽  
pp. 185-191
Author(s):  
Carlos Jordá Aragón ◽  
Juan Carlos Peñalver Cuesta ◽  
Nuria Mancheño Franch ◽  
Karol de Aguiar Quevedo ◽  
Francisco Vera Sempere ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Risk Analysis ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Early Stage ◽  
Small Cell ◽  
Competing Risk ◽  
Competing Risk Analysis ◽  
Small Cell Lung

scholarly journals Bayesian competing risk analysis: An application to nasopharyngeal carcinoma patients data

2020 ◽  
Vol 1 (1) ◽  
Author(s):  
Rakesh Kumar Saroj ◽  
K. Narasimha Murthy ◽  
Mukesh Kumar ◽  
Atanu Bhattacharjee ◽  
Kamalesh Kumar Patel
Keyword(s):  
Nasopharyngeal Carcinoma ◽  
Risk Analysis ◽  
Competing Risk ◽  
Competing Risk Analysis
Sign in / Sign up

Export Citation Format

Share Document